Pharmaceutical profile of DRC
Venturini et al. BMC Infectious Diseases 2014, 14(Suppl 1):S5 http://www.biomedcentral.com/1471-2334/14/S1/S5
13280–13285 / PNAS / September 9, 2008 / vol. 105 / no. 36
DHS Working Papers No. 124
Guidelines
Key Populations
2016 Update
Key population
2nd edition.
The tool kit provides learning objects and curricular content to support the competencies for those proficiency/trainee levels
BMC Res Notes (2016) 9:182 DOI 10.1186/s13104-016-1993-7
Supplement Article
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018 www.jaids.com
WHO Package of Essential NCD Interventions (PEN)
Accessed March 18,2019
Antimicrobial Resistance and Infection Control 2014,3 :31
In resource restriced countries
In resource restriced countries
Acta Med Peru. 2017;34(3):182-7; El objetivo del presente trabajo es conocer la magnitud del problema de la TB y sus principales características epidemiológicas en la población del penal de varones de penal de varones de Trujillo, que sirva de base para plantear las mejores soluciones terapéutic...as.
more
In Paraguay, 1.8% of the population are indigenous people. The Maká community
29 mainly live in urbanized areas in the Central Region. This study focuses on the epidemiology
30 of tuberculosis (TB) among indigenous Maká and the non-indigenous people living in the
31 Central Region, the biggest ...metropolitan area of the Paraguay.
more